The Significance of Fibrinogen Derivatives in Plasma in Human Renal Failure
Overview
Affiliations
The concentrations in plasma of fibrinogen derivatives fibrinopeptide A (FPA), beta 15-42 antigen and fragment E (FgE) antigen have been determined in patients with renal failure and compared to the concentrations of the platelet release products, beta-thromboglobulin (beta TG) and platelet factor 4 (PF4). In 'partial renal failure' (51Cr-EDTA clearance rate 4-60 ml/min) FPA, beta 15-42 antigen, FgE antigen and beta TG levels were significantly raised above a normal laboratory control group. These levels were further raised in a group of patients whose disease required regular maintenance haemodialysis (51Cr-EDTA clearance rate less than 4 ml/min). PF4 levels were not significantly raised in either group. A statistical analysis of all patient results revealed that FPA, beta 15-42 antigen and FgE antigen levels all correlated with beta TG levels but not with PF4 levels. It is known that beta TG is catabolized by the kidney but PF4 is not and that elevated beta TG levels in renal failure are caused by impaired elimination rather than increased production. These results suggest that the plasma levels of these three fibrinogen derivatives are elevated in renal disease at least in part by decreased elimination rather than by increased thrombin and plasmin activities alone.
Hsu C, Liao W, Chen W, Chang-Chien G, Lin S, Tain Y Biomedicines. 2023; 11(12).
PMID: 38137539 PMC: 10741387. DOI: 10.3390/biomedicines11123318.
Wu S, Yuan H, Zhou Y, Long Z, Peng Y, Peng F Nan Fang Yi Ke Da Xue Xue Bao. 2020; 40(4):556-561.
PMID: 32895144 PMC: 7225118. DOI: 10.12122/j.issn.1673-4254.2020.04.17.
Hayek S, Ko Y, Awad M, Ahmed H, Gray B, Hosny K Kidney Int Rep. 2017; 2(3):425-432.
PMID: 29142970 PMC: 5678674. DOI: 10.1016/j.ekir.2017.02.001.
Blood coagulation system in patients with chronic kidney disease: a prospective observational study.
Huang M, Wei R, Wang Y, Su T, Di P, Li Q BMJ Open. 2017; 7(5):e014294.
PMID: 28576889 PMC: 5541338. DOI: 10.1136/bmjopen-2016-014294.
Clot Structure: A Potent Mortality Risk Factor in Patients on Hemodialysis.
Schuett K, Savvaidis A, Maxeiner S, Lysaja K, Jankowski V, Schirmer S J Am Soc Nephrol. 2017; 28(5):1622-1630.
PMID: 28057772 PMC: 5407718. DOI: 10.1681/ASN.2016030336.